Brief: Takeda Canada British Columbia Reimburses Fruzaqlatm
16/12/2025 14:32
Dec 16 (Reuters) - Takeda Pharmaceutical Co Ltd 4502.T: TAKEDA CANADA: BRITISH COLUMBIA REIMBURSES FRUZAQLATM FOR TREATMENT OF METASTATIC COLORECTAL CANCER Source text: ID:nCNWYXkPBa Further company coverage: 4502.T ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Takeda Pharmaceutical
See all newsFactbox: Pharma sector doubles down on AI to slash costs, timelines
Nvidia-backed Iambic Therapeutics tumbles below IPO price
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Nvidia-backed Iambic Therapeutics launches IPO as biotechs buck market gloom (updated)